The latest trends in the treatment peritonitis of the patients on peritoneal dialysis;Současné trendy v léčbě peritonitid u nemocných léčených peritoneální dialýzou

Vnitrni Lekarstvi

Volumn 50, Issue 8, 2004, Pages 619-623

  Hájková, Božena ^a   Fixa, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antibiotics; Peritoneal dialysis; Peritonitis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; FLUCONAZOLE; GENTAMICIN; HEPARIN; NEOMYCIN; PSEUDOMONIC ACID; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL PERITONITIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRUG CHOICE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MYCOSIS; PERITONEAL DIALYSIS; PERITONITIS; REVIEW; SIDE EFFECT; MICROBIOLOGY;

HUMANS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS;

EID: 4444294857     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Biesen, W. V., Veys, N., Vanholder, R. et al.: Peritoneal dialysis related peritonitis: the art of rope-dancing. Nephrol. Dial. Transplant., 2002, 17, 1878-1882
2. Boer, W. H.: Daily nasal and exit - site mupirocin application greatly reduces the Staphylococcus aureus peritonitis rate without causing mupirocin resistance. Perit. Dial. Int., 2001, 21, 122
3. Burkart, J. M.: Microbiology and therapy of peritonitis in continuous peritoneal dialysis. Up To Date, 10, 3, 25, 2002
4. Burkart, J. M.: Diagnosis of peritonitis in continuous peritoneal dialysis. Up To Date, 10, 3, 2002
5. Costerton, J. W., Stewart, P. S., Greenberg, E. P.: Bacterial biofilms: a common cause of persistent infections. Science, 1999, 284, 1318-1322
6. Dasgupta, M. K., Larabie, M.: Biofilms in peritoneal dialysis. Perit. Dial. Int., 2001, 21, 213-217
7. Diaz-Buxo, J. A., Crawford, T. L., Bailie, G. R.: Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics. Perit. Dial. Int., 2001, 21, 197-199
8. Dombros, N. V.: Pathogenesis and management of malnutrition in chronic peritoneal dialysis patients. Nephrol. Dial. Transplant., 2001, 16, 111-113
9. Dunmire, R. B., Breyer, J. A.: Nontuberculous mycobacterial peritonitis during CAPD: Case report and review of diagnostic and therapeutic strategies. Am. J. Kidney Dis., 1991, 18, 126-131
10. Ekstrand, A., Kala Riitta, A., Honkanen, E.: Streptokinase or urokinase treatment in relapsing peritonitis. Perit. Dial. Int., 2001, 21, 112
11. Fontan, M. P., Carmona, A. R., Rosales, M.: Incidence and clinical significance of nasal and pericatheter colonization by Gram-negative bacteria among patients undergoing chronic peritoneal dialysis. Nephrol. Dial. Transplant., 2002, 17, 118-122
12. Gokal, R. A. et al.: Peritoneal catheters and exit-site practices toward optimum peritoneal access. Perit. Dial. Int., 1998, 18, 11
13. Huang, J. W., Hung, K. Y., Yen, Ch. J.: Comparison of infectious complications in peritoneal dialysis using either a twin - bag system or automated peritoneal dialysis. Nephrol. Dial. Transplant, 2001, 16, 604-607
14. Cheng, I. K., Chan, P. C., Chan, M. K.: Tuberculous peritonitis complicating long-term peritoneal dialysis. Report of 5 cases and review of the literature. Am. J. Nephrol., 1989, 9, 155-160
15. Chung, S. H., Heimburger, O., Stenvinkel, P. et al.: Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol. Dial. Transplant, 2003, 18, 590-597
16. Keane, W., Bailie, G., Boeschoten, E. et al.: Adult peritoneal dialysis related peritonitis treatment recommendations. Updated 2000. Perit. Dial. Int., 2000, 20, 396-411
17. Kokolina, E., Giamalis, P., Bibasi, E.: Fungal peritonitis complicating CAPD. Report of 18 cases and response to treatment. Perit. Dial. Int., 2001, 21, 113
18. Krediet, R. T., Westrhenen, R., Zweers, M. M. et al.: Clinical advantages of new peritoneal dialysis solutions. Nephrol. Dial. Transplant., 2002, 15, 16-18
19. Low, W. K., Chen, C. Y., Cheng, S. W. et al.: A prospective study of nystatin prophylaxis for Candida peritonitis. Am. J. Kidney Dis., 1996, 28, 549-552
20. Majkowski, N. L., Mendley, S. R.: Simultaneous removal and replacement of infected peritoneal dialysis catheters. Am. J. Kidney Dis., 1997, 29, 706
21. Oreopoulos, D. G.: Pathogenesis and management of complications of chronic peritoneal dialysis. Nephrol. Dial. Transplant., 2001, 16, 103-105
22. Oreopoulos, D. G.: The optimization of continuous ambulatory peritoneal dialysis. Kidney Int., 1999, 55, 1131-1149
23. Perez-Fontan, M., Rosales, M., Rodriguez, C. A. et al.: Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin. Adv. Perit. Dial., 1992, 8, 242
24. Piraino, B.: Prevention of peritonitis. Perit. Dial. Int., 1998, 18, 244-246
25. Quantrill, S. J., Woodhead, M. A., Bell, Ch. E. et al.: Peritoneal tuberculosis in patients receiving continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant., 2001, 16, 1024-1027
26. Senior, H. K., Brown, E. A., Clemenger, M.: Use of aminoglycosides in peritoneal dialysis peritonitis: A review of the effects on residual renal function. Perit. Dial. Int., 2001, 21, 120
27. Shemin, D., Maaz, D., Pierre, D.: Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am. J. Kidney Dis., 1999, 34, 14-16
28. Singhal, M. K., Vas, S. I., Oreopoulos, D. G.: Treatment of peritoneal dialysis catheter-related infections by simultaneous catheter removal and replacement. Is it safe? Perit. Dial. Int., 1998, 18, 565-569
29. Swartz, R., Messana, J., Reynolds, J. et al.: Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections. Kidney Int., 1991, 40, 1160
30. Thodis, E., Vas, S. I., Bargman, J. M. et al.: Nystatin prophylaxis: its inability fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit. Dial. Int., 1998, 18, 583-585
31. Thodis, E., Bhaskaran, S., Pasadakis, P. et al.: Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit. Dial. Int., 1998, 18, 244-246
32. Twardowski, Z. J., Prowant, B. F.: Current approach to exit-site infections in patients on peritoneal dialysis. Nephrol. Dial. Transplant., 1997, 12, 1284
33. Vargemezis, V., Thodis, E.: Prevention and management of peritonitis and exit-site infection in patients on continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant., 2001, 16, 106-108
34. Vas, S. I.: Single daily dose of aminoglycosides in the treatment of continuous ambulatory peritoneal dialysis peritonitis. Perit. Dial. Int., 1993, 13, 355
35. Vas, S. I.: Peritonitis. In: Peritoneal Dialysis, 3d ed., Nolph K. D., (Ed.). Kluwer Academic Publishers, Dordrecht, 1989, 261-272
36. Vas, S. I., Annigeri, R., Conly, J. et al.: Emergence of mupirocine-resistant Staph. aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit. Dial. Int., 2001, (6): 554-559